Bzowej N - Search Results

1

Evolution of viral quasispecies in interferon-treated patients with chronic hepatitis C virus infection.

Hassoba HM, Bzowej N, Berenguer M, Kim M, Zhou S, Phung Y, Grant R, Pessoa MG, Wright TL. Hassoba HM, et al. Among authors: bzowej n. J Hepatol. 1999 Oct;31(4):618-27. doi: 10.1016/s0168-8278(99)80340-7. J Hepatol. 1999. PMID: 10551384

2

Evolution of hepatitis C virus quasispecies in patients with severe cholestatic hepatitis after liver transplantation.

Pessoa MG, Bzowej N, Berenguer M, Phung Y, Kim M, Ferrell L, Hassoba H, Wright TL. Pessoa MG, et al. Among authors: bzowej n. Hepatology. 1999 Dec;30(6):1513-20. doi: 10.1002/hep.510300610. Hepatology. 1999. PMID: 10573532

3

Viral evolution of hepatitis C in injection drug users.

Dove L, Phung Y, Bzowej N, Kim M, Monto A, Wright TL. Dove L, et al. Among authors: bzowej n. J Viral Hepat. 2005 Nov;12(6):574-83. doi: 10.1111/j.1365-2893.2005.00640.x. J Viral Hepat. 2005. PMID: 16255758

4

Viral hepatitis and liver transplantation.

Bzowej NH, Wright TL. Bzowej NH, et al. J Gastroenterol Hepatol. 1999 May;14 Suppl:S53-60. doi: 10.1046/j.1440-1746.1999.01878.x. J Gastroenterol Hepatol. 1999. PMID: 10382640 Review.

5

Prophylaxis and treatment strategies for chronic viral hepatitis in liver transplant patients.

Bzowej NH, Wright TL. Bzowej NH, et al. Clin Liver Dis. 1997 Aug;1(2):323-39, ix. doi: 10.1016/s1089-3261(05)70274-9. Clin Liver Dis. 1997. PMID: 15562572 Review.

6

Prevalence and risk factors for hepatitis C virus infection at an urban Veterans Administration medical center.

Briggs ME, Baker C, Hall R, Gaziano JM, Gagnon D, Bzowej N, Wright TL. Briggs ME, et al. Among authors: bzowej n. Hepatology. 2001 Dec;34(6):1200-5. doi: 10.1053/jhep.2001.29303. Hepatology. 2001. PMID: 11732010

7

AASLD guidelines for treatment of chronic hepatitis B.

Terrault NA, Bzowej NH, Chang KM, Hwang JP, Jonas MM, Murad MH; American Association for the Study of Liver Diseases. Terrault NA, et al. Hepatology. 2016 Jan;63(1):261-83. doi: 10.1002/hep.28156. Epub 2015 Nov 13. Hepatology. 2016. PMID: 26566064 Free PMC article. No abstract available.

8

A 7 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis C.

Huang H, Shiffman ML, Friedman S, Venkatesh R, Bzowej N, Abar OT, Rowland CM, Catanese JJ, Leong DU, Sninsky JJ, Layden TJ, Wright TL, White T, Cheung RC. Huang H, et al. Among authors: bzowej n. Hepatology. 2007 Aug;46(2):297-306. doi: 10.1002/hep.21695. Hepatology. 2007. PMID: 17461418 Free article.

9

Efficacy of interferon alpha-2b induction therapy before retreatment for chronic hepatitis C.

Carr C, Hollinger FB, Yoffe B, Wakil A, Phillips J, Bzowej N, Leung J, Mirro K, Poordad F, Moore DH, Gish RG. Carr C, et al. Among authors: bzowej n. Liver Int. 2007 Oct;27(8):1111-8. doi: 10.1111/j.1478-3231.2007.01535.x. Liver Int. 2007. PMID: 17845540 Clinical Trial.

10

Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance.

Terrault NA, Lok ASF, McMahon BJ, Chang KM, Hwang JP, Jonas MM, Brown RS Jr, Bzowej NH, Wong JB. Terrault NA, et al. Among authors: bzowej nh. Hepatology. 2018 Apr;67(4):1560-1599. doi: 10.1002/hep.29800. Hepatology. 2018. PMID: 29405329 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

63 results

Search Page